Inventor
TANG YAJUN
CN15 patents
⚠️ This page may combine multiple inventors who share the name “TANG YAJUN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
REGENERON PHARMA
13 patentsUS9913461B2Mar 13, 2018
Genetically modified mouse whose genome comprises a humanized CD274 gene
REGENERON PHARMA4 citations83
US10070631B2Sep 11, 2018
Rodents having a humanized TMPRSS gene
REGENERON PHARMA4 citations82
US10070632B2Sep 11, 2018
Rodents having a humanized TMPRSS gene
REGENERON PHARMA5 citations82
US10881086B2Jan 5, 2021
Genetically modified mouse whose genome comprises a humanized CD274 gene
REGENERON PHARMA2 citations72
US12396444B2Aug 26, 2025
Mouse comprising a humanized TRKB locus
REGENERON PHARMA0 citations62
US12089575B2Sep 17, 2024
Genetically modified mouse that expresses humanized PD1 and PD-L1 proteins
REGENERON PHARMA0 citations62
US11419318B2Aug 23, 2022
Genetically modified rat comprising a humanized TRKB locus
REGENERON PHARMA1 citations62
US11910787B2Feb 27, 2024
Rodents having a humanized TMPRSS gene
REGENERON PHARMA0 citations61
US12082565B2Sep 10, 2024
Non-human animals models of retinoschisis
REGENERON PHARMA0 citations60
US12201096B2Jan 21, 2025
Non-human animals comprising a humanized coagulation factor 12 locus
REGENERON PHARMA0 citations57
US11737435B2Aug 29, 2023
Non-human animals comprising a humanized coagulation factor 12 locus
REGENERON PHARMA1 citations57
US12582104B2Mar 24, 2026
Mutant myocilin disease model and uses thereof
REGENERON PHARMA0 citations50
US10863729B2Dec 15, 2020
Rodents having a humanized TMPRSS gene
REGENERON PHARMA0 citations50